Related Experiment Videos
[Therapeutic advances against malaria in 2003]
1Département des maladies infectieuses parasitaires et tropicales, CHU Pitié-Salpêtrière, Université Paris 6, 91 bd de l'Hôpital, 75013 Paris, France. martin.danis@psl.ap-hop-paris.fr
Medecine Tropicale : Revue Du Corps De Sante Colonial
|October 29, 2003
Summary
New combination therapies, especially those including artemisinin, show promise for treating Plasmodium falciparum malaria. Research also explores novel antimalarial drugs to combat resistance.
Area of Science:
- Tropical medicine
- Malariology
- Pharmacology
Context:
- Uncomplicated Plasmodium falciparum malaria is a major health concern in tropical regions.
- Antimalarial drug resistance necessitates the development of new therapeutic strategies.
Purpose:
- To review recent therapeutic breakthroughs in malaria treatment over the past five years.
- To highlight promising new antimalarial agents and combination therapies.
Summary:
- Combination therapies, particularly those involving artemisinin derivatives, are a key focus.
- Novel antimalarial drug candidates with unique mechanisms of action are under investigation, including ferroquine, trioxanes, phosphatidyl choline inhibitors, fluoroquinolones, and fosfidomycine.
Impact:
- Advances in antimalarial drug development offer new hope for combating drug-resistant malaria.
- Improved treatment options are crucial for reducing the burden of malaria in endemic areas.